Publications by authors named "Jesper Sundell"

Claim this Profile
R
Rifampicin concentrations throughout the entire treatment duration of active tuberculosis; impact of sex and body mass index.
Teres Samuelsson, Elisabet Lönnermark, Jesper Sundell, Aylin Yilmaz

J Antimicrob Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concentration-QT modeling demonstrates that the selective mineralocorticoid receptor modulator, balcinrenone (AZD9977), does not prolong QT interval.
Jesper Sundell, Dinko Rekic, Johanna Melin, Susanne Johansson, Ahmad Ebrahimi

CPT Pharmacometrics Syst Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning pharmacometric covariate model structures with symbolic regression networks.
Ylva Wahlquist, Jesper Sundell, Kristian Soltesz

J Pharmacokinet Pharmacodyn· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic doses.
Joanna Parkinson, Jesper Sundell, Dinko Rekić, Karin Nelander, Hans Ericsson

Pharmacol Res Perspect· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Enzyme Induction and Polymorphism on the Pharmacokinetics of Isoniazid and Rifampin in Tuberculosis/HIV Patients.
Jesper Sundell, Emile Bienvenu, Sofia Birgersson, Angela Äbelö, Michael Ashton

Antimicrob Agents Chemother· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of efavirenz-based ART on the pharmacokinetics of rifampicin and its primary metabolite in patients coinfected with TB and HIV.
Jesper Sundell, Emile Bienvenu, Angela Äbelö, Michael Ashton

J Antimicrob Chemother· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Affecting the Pharmacokinetics of Pyrazinamide and Its Metabolites in Patients Coinfected with HIV and Implications for Individualized Dosing.
Jesper Sundell, Marie Wijk, Emile Bienvenu, Angela Äbelö, Kurt-Jürgen Hoffmann

Antimicrob Agents Chemother· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Based Assessment of Variability in Isoniazid Pharmacokinetics and Metabolism in Patients Co-Infected With Tuberculosis and HIV: Implications for a Novel Dosing Strategy.
Jesper Sundell, Emile Bienvenu, David Janzén, Sofia Birgersson, Angela Äbelö

Clin Pharmacol Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics and Pharmacogenetics of Ethambutol in Adult Patients Coinfected with Tuberculosis and HIV.
Jesper Sundell, Emile Bienvenu, Sofia Birgersson, Angela Äbelö, Michael Ashton

Antimicrob Agents Chemother· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous quantification of four first line antitubercular drugs and metabolites in human plasma by hydrophilic interaction chromatography and tandem mass spectrometry.
Jesper Sundell, Emile Bienvenu, Sofia Birgersson, Angela Äbelö, Michael Ashton

J Chromatogr B Analyt Technol Biomed Life Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.
Therese Ericsson, Jesper Sundell, Angelica Torkelsson, Kurt-Jürgen Hoffmann, Michael Ashton

Xenobiotica· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis